Nice work, Madame;) IPG certainly isn't behaving like a stock...

First 60 Last

Share
Profile

Follow
writer

5,837 Posts.

3182

05/10/15

15:02

Post #: 16116266
Share

Originally posted by madamswer ↑

"This stock reminds me of LNG when it was over $4. And i was telling everything to sell and was ridiculed for saying this. What is it now well under $1.50."

Now, now, TeTeTe.

You really should try to be more sincere with your boasting because not all readers might be as well versed with some of the true details your travails on the LNG threads.

What you omitted to mention is that you were short the stock in the $2.50 range, claiming it was worth 30c, and then when it rose into the mid $3.00 ranged you covered your shorts.

That's what is known in colloquial parlance as zigging exactly while you should have been zagging.

(In fact, one would struggle to find evidence of anyone getting something so wrong.)

In order to set the record straight, here's the paper trail:

“I am still short from $2.50 and $3.15. Still looking for a next move down between $1 and $1.50.
This is based on value metrics and charts!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!"
Post #: 14683300
Date: 02/02/2015
Poster: TeTeTe
LNG Price at the time of posting: $2.98

And then, there's this little addendum, posted the very next day:

“Considering anything over 30c is overvalued. Maybe some people are slowly waking up to the this fact. I am even more confident after today that $1 is coming. It is called the waiting game.”

Post #: 14689634
Date: 03/02/2015
Poster: TeTeTe
Price at the time of posting: $2.99

And then, a few weeks' later, we got this bombshell:

“I covered my shorts this morning at $4.60, based on the charts.”
Post #: 15186966
Date: 30/04/2015
Poster: TeTeTe
Price at the time of posting: $4.70

All in all, quite a laughable sequence of events.

Shorting at $2.50 and then covering at $4.60... I can't remember ever encountering such a tragic case of "Selling-Low and Buying-High"

Expand

Nice work, Madame

IPG certainly isn't behaving like a stock fearful of shares coming out of escrow.

The opposite

1PG Price at posting: $4.84 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

First 60 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Nice work, Madame;) IPG certainly isn't behaving like a stock...

Top Stories

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Monash IVF shares cater 25% – Disaster or deep-value play?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News